Sai Life Sciences Limited approved the allotment of 2,44,281 equity shares under its employee stock option schemes, following the exercise of vested options.

The allotment, cleared by the company’s board on April 23, 2026, includes 44,500 shares issued under the ESOP 2008 plan and 1,99,781 shares under the Management ESOP Plan 2018 (MESOP 2018). 

The company realized over Rs 3.38 crore when employees exercised stock options at predetermined prices for the shares, which had a face value of Re 1 each. 

Post-allotment, the company’s total issued share capital increased to 21.20 crore equity shares. 

The ESOP and MESOP programmes are designed to attract, retain and incentivise employees, with vesting structures extending up to five years and exercise linked to continued employment. 

The disclosure was made under Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations.